Toby Basey-Fisher founded Entia in 2015 to address the challenges of poorly personalized cancer therapy.

Toby received his PhD in Biomedical Physics from Imperial College London where he also holds an honorary lectureship. He served as a board member at BIVDA and is a Blavatnik Enterprise Fellow of the Royal Academy of Engineering. He has overseen the growth of Entia from a university spin-out to an established market leader in oncology remote patient monitoring.